AI/ML Innovations Inc. (AIML.CN)

CAD 0.07

(0.0%)

EBITDA Summary of AI/ML Innovations Inc.

  • AI/ML Innovations Inc.'s latest annual EBITDA in 2023 was -1.66 Million CAD , down -27.73% from previous year.
  • AI/ML Innovations Inc.'s latest quarterly EBITDA in 2024 Q1 was -118.67 Thousand CAD , up 82.1% from previous quarter.
  • AI/ML Innovations Inc. reported an annual EBITDA of -1.3 Million CAD in 2022, up 60.93% from previous year.
  • AI/ML Innovations Inc. reported an annual EBITDA of -3.41 Million CAD in 2021, down -133.05% from previous year.
  • AI/ML Innovations Inc. reported a quarterly EBITDA of -431.29 Thousand CAD for 2023 Q2, down -60.94% from previous quarter.
  • AI/ML Innovations Inc. reported a quarterly EBITDA of -267.99 Thousand CAD for 2023 Q1, down -9.46% from previous quarter.

Annual EBITDA Chart of AI/ML Innovations Inc. (2023 - 1997)

Historical Annual EBITDA of AI/ML Innovations Inc. (2023 - 1997)

Year EBITDA EBITDA Growth
2023 -1.66 Million CAD -27.73%
2022 -1.3 Million CAD 60.93%
2021 -3.41 Million CAD -133.05%
2020 -1.43 Million CAD -633.96%
2019 -176.55 Thousand CAD -100.56%
2018 -31.01 Thousand CAD -3.38%
2017 9641.00 CAD 29.17%
2016 - CAD 68.77%
2015 -417.83 Thousand CAD 24.53%
2014 -563.42 Thousand CAD -52.22%
2013 -370.13 Thousand CAD 38.37%
2012 -600.6 Thousand CAD 82.59%
2011 -3.44 Million CAD -110.93%
2010 -1.63 Million CAD -775.29%
2009 -186.83 Thousand CAD -1813.87%
2008 -9762.00 CAD 92.27%
2007 -195.28 Thousand CAD 20.83%
2006 -159.5 Thousand CAD -77.73%
2005 -298.67 Thousand CAD -52.23%
2004 -58.95 Thousand CAD 80.4%
2003 -300.78 Thousand CAD -100.36%
2002 -150.11 Thousand CAD -109.16%
2001 1.63 Million CAD 688.9%
2000 -278.15 Thousand CAD 9.65%
1999 -431.29 Thousand CAD 42.24%
1998 -838.61 Thousand CAD 18.2%
1997 -969.22 Thousand CAD 0.0%

Peer EBITDA Comparison of AI/ML Innovations Inc.

Name EBITDA EBITDA Difference
Diagnamed Holdings Corp. -100.27 Thousand CAD -1560.388%
Pangenomic Health Inc. -2.71 Million CAD 38.605%
nDatalyze Corp. -290.5 Thousand CAD -473.109%
Treatment.Com International Inc. -3.64 Million CAD 54.342%
Unidoc Health Corp. -2.18 Million CAD 23.731%